Iranian
Biomedical Journal
Volume 29, Issue 1 And 2 (1-2025)
IBJ 2025, 29(1 And 2): 49-56 |
Back to browse issues page
Ethics code: IR.PII.REC.1400.016
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Fereydouni T, Zargar S J, Seifi S, Sheikhpour M. Expression Pattern Study of miR-200a and XIAP Gene in the Non-small Cell Lung Cancer Patients’ blood. IBJ 2025; 29 (1 and 2) :49-56
URL: http://ibj.pasteur.ac.ir/article-1-4354-en.html
URL: http://ibj.pasteur.ac.ir/article-1-4354-en.html
Expression Pattern Study of miR-200a and XIAP Gene in the Non-small Cell Lung Cancer Patients’ blood
Abstract:
Background: In NSCLC, miR-200a plays a significant role in apoptosis. One of the genes involved in this pathway is XIAP, which has been shown anti-apoptotic activity. Research has indicated a significant association between miR-200a and the XIAP gene in this pathway. The present study investigated the expression profiles of miR-200a and the XIAP gene in NSCLC patients compared to normal individuals, as well as cancer cells compared to normal and apoptosis-inducing conditions.
Methods: In this study, 40 blood specimens were collected from NSCLC patients and 40 from healthy individuals. After isolating plasma and PBMC from these samples, we analyzed the miR-200a and XIAP gene expression levels using real-time PCR. Subsequently, normal and lung cancer cells were treated with paclitaxel as a model of apoptosis. The antiproliferative effects and induction of apoptosis were then evaluated using the MTT and flow cytometry assays, respectively. Finally, the expression patterns of miR-200a and the XIAP gene were investigated through a real-time PCR method.
Results: Results indicated that the miR-200a expression level was lower in NSCLC patients than in healthy ones, while the expression level of XIAP gene increased in the NSCLC Patients’ blood. The MTT and flow cytometry results demonstrated a decreased proliferation and increased apoptosis rates in two lung line cells (A549 and MRC5) treated with paclitaxel. XIAP expression level also decreased in A549 cells treated with paclitaxel compared to untreated A549 cells.
Conclusion: MiR-200a may be associated with the XIAP gene expression and the induction of the apoptosis pathway in NSCLC.
Methods: In this study, 40 blood specimens were collected from NSCLC patients and 40 from healthy individuals. After isolating plasma and PBMC from these samples, we analyzed the miR-200a and XIAP gene expression levels using real-time PCR. Subsequently, normal and lung cancer cells were treated with paclitaxel as a model of apoptosis. The antiproliferative effects and induction of apoptosis were then evaluated using the MTT and flow cytometry assays, respectively. Finally, the expression patterns of miR-200a and the XIAP gene were investigated through a real-time PCR method.
Results: Results indicated that the miR-200a expression level was lower in NSCLC patients than in healthy ones, while the expression level of XIAP gene increased in the NSCLC Patients’ blood. The MTT and flow cytometry results demonstrated a decreased proliferation and increased apoptosis rates in two lung line cells (A549 and MRC5) treated with paclitaxel. XIAP expression level also decreased in A549 cells treated with paclitaxel compared to untreated A549 cells.
Conclusion: MiR-200a may be associated with the XIAP gene expression and the induction of the apoptosis pathway in NSCLC.
Type of Study: Full Length/Original Article |
Subject:
Molecular Genetics & Genomics
References
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. [DOI:10.3322/caac.21660]
2. Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5(3):288-300. [DOI:10.21037/tlcr.2016.06.07]
3. Shah NUD, Ali MN, Ganai BA, Mudassarb S, Khan MS, Kour J, et al. Association of promoter methylation of RASSF1A and KRAS mutations in non-small cell lung carcinoma in Kashmiri population (India). Heliyon. 2020;6(2):e03488. [DOI:10.1016/j.heliyon.2020.e03488]
4. Wu KL, Tsai YM, Lien CT, Kuo PL, Hung JY. The roles of MicroRNA in lung cancer. Int J Mol Sci. 2019;20(7):1611. [DOI:10.3390/ijms20071611]
5. Bucur O. MicroRNA regulators of apoptosis in cancer. Discoveries. 2016;4(1):e57. [DOI:10.15190/d.2016.4]
6. Tu H, Costa M. XIAP's Profile in human cancer. Biomolecules. 2020;10(11):1493. [DOI:10.3390/biom10111493]
7. Hundsdoerfer P, Dietrich I, Schmelz K, Eckert C, Henze G. XIAP expression is post-transcriptionally upregulated in childhood ALL and is associated with glucocorticoid response in T-cell ALL. Pediatr Blood Cancer. 2010;55(2):260-6. [DOI:10.1002/pbc.22541]
8. Tan T, Xu XH, Lu XH, Wang XW. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2. Eur Rev Med Pharmacol Sci. 2020;24(2):712-20.
9. Feng X, Wang Z, Fillmore R, Xi Y. MiR-200, a new star miRNA in human cancer. Cancer Lett. 2014;344(2):166-73. [DOI:10.1016/j.canlet.2013.11.004]
10. Muralidhar GG, Barbolina MV. The miR-200 family: Versatile players in epithelial ovarian cancer. Int J Mol Sci. 2015;16(8):16833-47. [DOI:10.3390/ijms160816833]
11. Klicka K, Grzywa TM, Mielniczuk A, Klinke A, Włodarski PK. The role of miR-200 family in the regulation of hallmarks of cancer. Front Oncol. 2022;12:965231. [DOI:10.3389/fonc.2022.965231]
12. Du M, Wang J, Chen H, Wang S, Chen L, Xu Y, et al. MicroRNA-200a suppresses migration and invasion and enhances the radiosensitivity of NSCLC cells by inhibiting the HGF/c-Met signaling pathway. Oncol Rep. 2019;41(3):1497-1508. [DOI:10.3892/or.2018.6925]
13. Wang T, Tang X, Liu Y. LncRNA-ATB promotes apoptosis of non-small cell lung cancer cells through MiR-200a/β-Catenin. J Buon. 2019;24(6):2280-6.
14. Jin H, Xue L, Mo L, Zhang D, Guo X, Xu J, et al. Downregulation of miR-200c stabilizes XIAP mRNA and contributes to invasion and lung metastasis of bladder cancer. Cell Adh Migr. 2019;13(1):236-48. [DOI:10.1080/19336918.2019.1633851]
15. Huang C, Zeng X, Jiang G, Liao X, Liu C, Li J, et al. XIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cell. J Hematol Oncol. 2017;10(1):6. [DOI:10.1186/s13045-016-0376-9]
16. Huang Y, Bao T, Li Z, Ji G, Zhang L. Function of miR-200a in proliferation and apoptosis of non-small cell lung cancer cells. Oncol Lett. 2020;20(2):1256-62. [DOI:10.3892/ol.2020.11649]
17. Nadal E, Truini A, Nakata A, Lin J, Reddy RM, Chang AC, et al. A novel serum 4-microRNA signature for lung cancer detection. Sci Rep. 2015;5:12464. [DOI:10.1038/srep12464]
18. Ren Y, Han X, Yu K, Sun S, Zhen L, Li Z, et al. MicroRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells. Mol Med Rep. 2014;10(1):315-21. [DOI:10.3892/mmr.2014.2222]
19. Shahsavani M, Baghbani-Arani F, Sheikhpour M. The expression profile evaluation of Mir-125b in tuberculosis and non-small cell lung cancer patients. Clin Cancer Invest J. 2021;10(2): 60-4.
20. Nawara HM, Afify SM, Hassan G, Zahra MH, Seno A, Seno M. Paclitaxel-based chemotherapy targeting cancer stem cells from mono-to combination therapy. Biomedicines. 2021;9(5):500. [DOI:10.3390/biomedicines9050500]
21. Alexander M, Kim SY, Cheng H. Update 2020: Management of non-small cell lung cancer. Lung. 2020;198(6):897-907. [DOI:10.1007/s00408-020-00407-5]
22. Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J, et al. MiR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemother Pharmacol. 2012;69(3):723-31. [DOI:10.1007/s00280-011-1752-3]
23. Qin S, Yang C, Zhang B, Li X, Sun X, Li G, et al. XIAP inhibits mature Smac-induced apoptosis by degrading it through ubiquitination in NSCLC. Int J Oncol. 2016;49(4):1289-96. [DOI:10.3892/ijo.2016.3634]
24. Abolfathi H, Sheikhpour M, Soltani BM, Fahimi H. The comparison and evaluation of the miR-16, miR-155 and miR-146a expression pattern in the blood of TB and NSCLC patients: A Research paper. Gene Rep. 2021;22:100967. [DOI:10.1016/j.genrep.2020.100967]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |